2-151494161-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_001164508.2(NEB):c.24579G>A(p.Ser8193=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000169 in 1,601,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S8193S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001164508.2 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.24579G>A | p.Ser8193= | splice_region_variant, synonymous_variant | 174/182 | ENST00000427231.7 | NP_001157979.2 | |
NEB | NM_001164508.2 | c.24579G>A | p.Ser8193= | splice_region_variant, synonymous_variant | 174/182 | ENST00000397345.8 | NP_001157980.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.24579G>A | p.Ser8193= | splice_region_variant, synonymous_variant | 174/182 | 5 | NM_001164508.2 | ENSP00000380505 | P5 | |
NEB | ENST00000427231.7 | c.24579G>A | p.Ser8193= | splice_region_variant, synonymous_variant | 174/182 | 5 | NM_001164507.2 | ENSP00000416578 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000343 AC: 8AN: 233398Hom.: 0 AF XY: 0.0000476 AC XY: 6AN XY: 126034
GnomAD4 exome AF: 0.0000159 AC: 23AN: 1449934Hom.: 0 Cov.: 31 AF XY: 0.0000208 AC XY: 15AN XY: 720014
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74268
ClinVar
Submissions by phenotype
Nemaline myopathy 2 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | This sequence change affects codon 8228 of the NEB mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the NEB protein. This variant also falls at the last nucleotide of exon 175, which is part of the consensus splice site for this exon. This variant is present in population databases (rs202048855, gnomAD 0.006%). This variant has been observed in individual(s) with nemaline myopathy (PMID: 24725366; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as c.24579G>A. ClinVar contains an entry for this variant (Variation ID: 521691). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | 3billion | Jan 03, 2022 | The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000521691).It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000034, PM2_M). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least one similarly affected unrelated individual (3billion dataset, PM3_M). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 12, 2021 | NM_001271208.1(NEB):c.24684G>A(S8228=) is a silent variant classified as likely pathogenic in the context of NEB-related nemaline myopathy. S8228= has been observed in cases with relevant disease (PMID: 32222963, 25205138, 23726790, 26562614). Functional assessments of this variant are not available in the literature. S8228= has been observed in population frequency databases (gnomAD: AFR 0.01%). In summary, NM_001271208.1(NEB):c.24684G>A(S8228=) is a silent variant that has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. - |
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | - | This synonymous variant affects the last nucleotide of exon 174 of the NEB gene and is predicted to abolish the canonical splice donor site of intron 174 by in silico tools (MaxEntScan, GeneSplicer); however, to our knowledge, no RNA-base splicing analysis has been performed to clarify the effect of this alteration on splicing. This variant has been previously reported as a compound heterozygous change or together with another NEB variant, in patients with Nemaline Myopathy (PMID: 24725366, 30467404, 29669168). In one patient, electron microscopy studies showed elongated nemaline bodies in the perinuclear and/or subsarcolemmal areas of muscle fibres (PMID: 24725366). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.003428% (8/233398) and thus is presumed to be rare. Based on the available evidence, the c.24579G>A (p.Ser8193=) variant is classified as Pathogenic. - |
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2017 | - - |
Nemaline myopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Muscle and Diseases Team, Institut de Génétique et Biologie Moléculaire et Cellulaire | Mar 01, 2024 | PS3+PM1+PM2+PM3+PP3+PP4+PP5 - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 22, 2023 | Variant located in the final nucleotide of the exon in a gene for which loss of function is a known mechanism of disease, and both splice predictors and evolutionary conservation support a deleterious effect, although in the absence of functional evidence the actual effect of this sequence change is unknown.; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25205138, 32222963, 35081925, 29669168, 24725366) - |
Arthrogryposis multiplex congenita 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 29, 2024 | - - |
Nemaline myopathy 2;C5543431:Arthrogryposis multiplex congenita 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 27, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at